XML 16 R4.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Thousands, $ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Revenues      
Total Revenues $ 5,019.4 $ 4,689.7 $ 4,883.6
Expenses      
Compensation and benefits 753.1 837.0 856.5
Technology 188.6 192.6 198.5
Professional fees and outside services 137.4 151.7 191.3
Amortization of purchased intangibles 227.7 237.6 311.2
Depreciation and amortization 134.9 147.8 153.2
Licensing and other fee agreements 320.0 236.9 244.9
Other 241.8 240.9 290.6
Total Expenses 2,003.5 2,044.5 2,246.2
Operating Income 3,015.9 2,645.2 2,637.4
Non-Operating Income (Expense)      
Investment income 2,198.4 306.9 182.7
Interest and other borrowing costs (162.7) (166.9) (166.2)
Equity in net earnings (losses) of unconsolidated subsidiaries 301.1 245.8 190.6
Other income (expense) (1,862.4) 342.6 (122.4)
Total Non-Operating 474.4 728.4 84.7
Income before Income Taxes 3,490.3 3,373.6 2,722.1
Income tax provision 799.3 736.7 615.7
Net income 2,691.0 2,636.9 2,106.4
Net Income (Loss) Attributable to Noncontrolling Interest 0.0 0.5 1.2
Net income attributable to CME Group 2,691.0 2,636.4 2,105.2
Net Income Attributable to Common Shareholders of CME Group $ 2,657.2 $ 2,617.1 $ 2,105.2
Earnings per Common Share Attributable to CME Group:      
Basic $ 7.41 $ 7.30 $ 5.88
Diluted $ 7.40 $ 7.29 $ 5.87
Weighted Average Number of Common Shares:      
Basic 358,713 358,340 357,764
Diluted 359,181 358,929 358,524
Clearing and Transaction Fees [Member]      
Revenues      
Total Revenues $ 4,142.7 $ 3,765.1 $ 3,897.4
MarketData [Member]      
Revenues      
Total Revenues 610.9 576.9 545.4
OtherRevenue [Member]      
Revenues      
Total Revenues $ 265.8 $ 347.7 $ 440.8